GlaxoSmithKline
GSK
#209
Rank
ยฃ73.35 B
Marketcap
ยฃ36.34
Share price
-0.33%
Change (1 day)
38.82%
Change (1 year)

GlaxoSmithKline (GSK) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ3.33 Billion

According to GlaxoSmithKline's latest financial reports the company has ยฃ3.33 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

GlaxoSmithKline - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ3.71 B-25.6%
2023-12-31ยฃ4.99 B-34.97%
2022-12-31ยฃ7.67 B85.66%
2021-12-31ยฃ4.13 B-32.98%
2020-12-31ยฃ6.17 B34.54%
2019-12-31ยฃ4.58 B15.87%
2018-12-31ยฃ3.95 B1.2%
2017-12-31ยฃ3.91 B-21.56%
2016-12-31ยฃ4.98 B-15.56%
2015-12-31ยฃ5.90 B33.99%
2014-12-31ยฃ4.40 B-21.3%
2013-12-31ยฃ5.60 B31.3%
2012-12-31ยฃ4.26 B-27.69%
2011-12-31ยฃ5.89 B-5.5%
2010-12-31ยฃ6.24 B-10.1%
2009-12-31ยฃ6.94 B1.05%
2008-12-31ยฃ6.87 B51.43%
2007-12-31ยฃ4.53 B49.28%
2006-12-31ยฃ3.03 B-41.92%
2005-12-31ยฃ5.23 B31.56%
2004-12-31ยฃ3.97 B15.26%
2003-12-31ยฃ3.45 B39.76%
2002-12-31ยฃ2.46 B6.36%
2001-12-31ยฃ2.32 B-35.37%
2000-12-31ยฃ3.59 B82.71%
1999-12-31ยฃ1.96 B4.3%
1998-12-31ยฃ1.88 B13.42%
1997-12-31ยฃ1.66 B31.7%
1996-12-31ยฃ1.26 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
AstraZeneca
AZN
ยฃ6.14 B 84.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
ยฃ11.24 B 237.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ13.67 B 309.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ7.32 B 119.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
ยฃ7.84 B 135.17%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
ยฃ1.65 B-50.43%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
ยฃ0.48 B-85.42%๐Ÿ‡บ๐Ÿ‡ธ USA